MARKET

JAGX

JAGX

Jaguar Health Inc
NASDAQ
4.070
-0.020
-0.49%
After Hours: 4.090 +0.02 +0.49% 19:58 07/12 EDT
OPEN
4.120
PREV CLOSE
4.090
HIGH
4.227
LOW
4.030
VOLUME
335.36K
TURNOVER
0
52 WEEK HIGH
41.76
52 WEEK LOW
3.072
MARKET CAP
26.18M
P/E (TTM)
-0.0518
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at JAGX last week (0701-0705)?
Weekly Report · 6d ago
Weekly Report: what happened at JAGX last week (0624-0628)?
Weekly Report · 07/01 11:47
Jaguar Health regains compliance with Nasdaq's listing rule
Seeking Alpha · 06/26 12:42
JAGUAR HEALTH INC - REGAINS COMPLIANCE WITH NASDAQ S BID PRICE REQUIREMENT
Reuters · 06/26 12:31
JAGUAR HEALTH INC - TO REPORT PIVOTAL PHASE 3 ONTARGET TRIAL RESULTS FOR ITS CANCER SUPPORTIVE CARE DRUG CROFELEMER ON OR BEFORE JULY 23
Reuters · 06/26 12:31
Weekly Report: what happened at JAGX last week (0617-0621)?
Weekly Report · 06/24 11:56
Jaguar Health Stockholders Approve Key Proposals at 2024 Meeting
TipRanks · 06/21 23:00
Weekly Report: what happened at JAGX last week (0610-0614)?
Weekly Report · 06/17 11:45
More
About JAGX
Jaguar Health, Inc. is a commercial-stage pharmaceuticals company. The Company is focused on developing novel proprietary prescription medicines sustainably derived from plants from rainforest areas for people and animals with gastrointestinal distress. It operates through two segments: human health and animal health. The animal health segment is focused on developing and commercializing prescription and non-prescription products for companion and production animals. The human health segment is focused on developing and commercializing of human products and the ongoing commercialization of Mytesi, which is used for the symptomatic relief of non-infectious diarrhea in adults with human immunodeficiency virus (HIV)/ acquired immunodeficiency syndrome (AIDS) on antiretroviral therapy. The Canalevia-CA1 is for the treatment of chemotherapy-induced diarrhea (CID) in dogs. Its subsidiary Napo Pharmaceuticals, Inc. focuses on developing and commercializing human prescription pharmaceuticals.

Webull offers Jaguar Health Inc stock information, including NASDAQ: JAGX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, JAGX stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading JAGX stock methods without spending real money on the virtual paper trading platform.